To report prostate cancer outcomes, toxicity, and quality of life (QOL) in men treated with proton beam therapy (PBT).
Patients were enrolled in a prospective trial. All participants received 75.
To report prostate cancer outcomes, toxicity, and quality of life (QOL) in men treated with proton beam therapy (PBT).
Patients were enrolled in a prospective trial. All participants received 75.